Mon - Sat : 10.00 AM - 4.00PM Sunday : Closed
For people living with frequent or chronic migraines, preventive treatments may help reduce the number of migraine attacks over time.
At Jacobs Pain Centre in Toronto, Vyepti® migraine treatment may be considered for people who continue to experience migraines despite other preventive medications.
Vyepti® is a prescription medication designed to help prevent migraine attacks in adults.
Vyepti® (eptinezumab) is a medication known as a CGRP inhibitor.
CGRP (calcitonin gene-related peptide) is a protein involved in migraine pathways. By targeting this pathway, Vyepti® helps reduce migraine frequency for some patients.
Vyepti® is administered as an intravenous infusion, typically once every three months.
This treatment may be considered for people who:
Vyepti® is administered through an IV infusion in a clinical setting.
The infusion typically takes about 30 minutes, and people can return home afterward.
Vyepti® is typically administered once every three months.
No. Vyepti® is used to prevent migraines, not treat an active migraine attack.
Jacobs Pain Centre, 8920 Woodbine Ave, Ste. 102, Markham, ON L3R 9W9
Since 2002, Jacob’s Pain Centre has provided effective, comprehensive pain management through a multidisciplinary approach. We combine evidence-based treatments with supportive care to deliver accurate diagnoses and personalized pain management plans.
Copyright © 2025. All Rights Reserved.
